Latest return on equity
Denali Therapeutics Return on equity
Denali Therapeutics (DNLI) return on equity with its verified observation date.
Direct answer
Denali Therapeutics's return on equity is -54.93%.
The verified market snapshot reports -54.93%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 24, 2026.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -54.93%
Explore related company data
View Denali Therapeutics's market capitalizationView Denali Therapeutics's price-to-book ratioView Denali Therapeutics's 52-week price rangeView Denali Therapeutics's profit marginView Denali Therapeutics's debt-to-equity ratioView all Denali Therapeutics key metricsReturn to Denali Therapeutics profile